Updates matching "Childhood Cancer Research"

More than 200 childhood cancer advocates will be on Capitol Hill on May 2 to ask Congress to support initiatives that would increase research and improve treatment, leading to better outcomes for children with cancer.

ACS CAN applauds the introduction of the Research to Accelerate Cures and Equity (RACE) for Children Act (H.R. 1231/S. 456) – bipartisan legislation that would expand drug research for children with cancer, leading to better outcomes for pediatric patients.

The Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act (H.R. 820 and S. 292) introduced yesterday in Congress would help improve survivorship, treatment and access to care for childhood cancer patients and expand research into childhood cancers and care.

On December 6, the U.S. House of Representatives approved the bipartisan Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which advances pediatric cancer research and increases transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH).

A first of its kind joint report today from the American Cancer Society and Alliance for Childhood Cancer compiles the latest information related to pediatric cancer, including statistics and trends, a current list of drugs used to treat pediatric cancers, ongoing pediatric cancer clinical trials, and research funding levels.

WASHINGTON, D.C. – August 11, 2011 – A majority of states are falling short on legislative solutions to prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). In a year consumed by budget shortfalls and legislative challenges, many